CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($) shares in Thousands, $ in Thousands	Total	2021 Notes	Preferred Stock	Common Stock	Common Stock 2021 Notes	Treasury Stock	Additional Paid-In Capital	Additional Paid-In Capital 2021 Notes	Accumulated Deficit
Balance at the beginning (in shares) at Dec. 31, 2021			307	1,254		0
Balance at the beginning at Dec. 31, 2021	$ (8,572)		$ 1	$ 0		$ 0	$ 61,197		$ (69,770)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(19,376)								(19,376)
Stock-based compensation	1,924						1,924
Exercise of stock options (in shares)				6
Exercise of stock options	127						127
Conversion of stock (in shares)			(307)	307	207
Conversion of stock		$ 33,024	$ (1)	$ 0			1	$ 33,024
Merger and recapitalization, net of fees (in shares)				100
Merger and recapitalization, net of fees	27,997						27,997
Stockholder contribution for debt issuance costs	924						924
Escrow shares derivative liability (in shares)				81
Escrow shares derivative liability	(6,867)						(6,867)
Private warrants derivative liability	(3,916)						(3,916)
Forward share purchase agreement derivative liability (in shares)				193
Forward share purchase agreement derivative liability	(14,170)						(14,170)
Stockholder earnout rights derivative liability	(26,131)						(26,131)
Balance at the end (in shares) at Mar. 31, 2022			0	2,148		0
Balance at the end at Mar. 31, 2022	(15,036)		$ 0	$ 0		$ 0	74,110		(89,146)
Balance at the beginning (in shares) at Dec. 31, 2021			307	1,254		0
Balance at the beginning at Dec. 31, 2021	(8,572)		$ 1	$ 0		$ 0	61,197		(69,770)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	10,837
Balance at the end (in shares) at Sep. 30, 2022				2,152		(154)
Balance at the end at Sep. 30, 2022	(1,398)			$ 0		$ (31,663)	89,198		(58,933)
Balance at the beginning (in shares) at Mar. 31, 2022			0	2,148		0
Balance at the beginning at Mar. 31, 2022	(15,036)		$ 0	$ 0		$ 0	74,110		(89,146)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	14,759								14,759
Stock-based compensation	464						464
Exercise of stock options (in shares)				1
Exercise of stock options	30						30
Balance at the end (in shares) at Jun. 30, 2022				2,149		0
Balance at the end at Jun. 30, 2022	217			$ 0		$ 0	74,604		(74,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	15,454								15,454
Shares canceled				(1)
Stock-based compensation	771						771
Exercise of stock options	1						1
Settlement of forward share purchase agreement derivative liability	(17,841)						(17,841)
Purchase of treasury stock (in shares)						(154)
Purchase of treasury stock						$ 31,663	(31,663)
Issuance of Common Stock upon vesting of restricted stock units (in shares)				4
Balance at the end (in shares) at Sep. 30, 2022				2,152		(154)
Balance at the end at Sep. 30, 2022	(1,398)			$ 0		$ (31,663)	89,198		(58,933)
Balance at the beginning (in shares) at Dec. 31, 2022			0	2,164		(154)
Balance at the beginning at Dec. 31, 2022	(6,407)		$ 0	$ 0		$ (31,663)	89,956		(64,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(5,397)								(5,397)
Stock-based compensation	658						658
Issuance of Common Stock under ESPP (in shares)				14
Issuance of Common Stock under ESPP	120						120
Issuance of Common Stock upon vesting of restricted stock units (in shares)				14
Balance at the end (in shares) at Mar. 31, 2023			0	2,192		(154)
Balance at the end at Mar. 31, 2023	(11,026)		$ 0	$ 0		$ (31,663)	90,734		(70,097)
Balance at the beginning (in shares) at Dec. 31, 2022			0	2,164		(154)
Balance at the beginning at Dec. 31, 2022	(6,407)		$ 0	$ 0		$ (31,663)	89,956		(64,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(9,043)
Balance at the end (in shares) at Sep. 30, 2023				2,311		(154)
Balance at the end at Sep. 30, 2023	(13,047)					$ (31,663)	92,359		(73,743)
Balance at the beginning (in shares) at Mar. 31, 2023			0	2,192		(154)
Balance at the beginning at Mar. 31, 2023	(11,026)		$ 0	$ 0		$ (31,663)	90,734		(70,097)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(1,436)								(1,436)
Stock-based compensation	580						580
Issuance of Common Stock upon vesting of restricted stock units (in shares)				31
Balance at the end (in shares) at Jun. 30, 2023				2,223		(154)
Balance at the end at Jun. 30, 2023	(11,882)			$ 0		$ (31,663)	91,314		(71,533)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(2,210)								(2,210)
Stock-based compensation	997						997
Reverse stock split , Shares				34
Reverse stock split				$ 0			0
Issuance of Common Stock under ESPP (in shares)				6
Issuance of Common Stock under ESPP	48						48
Issuance of Common Stock upon vesting of restricted stock units (in shares)				48
Balance at the end (in shares) at Sep. 30, 2023				2,311		(154)
Balance at the end at Sep. 30, 2023	$ (13,047)					$ (31,663)	$ 92,359		$ (73,743)